SEATTLE — A study based on IRIS Registry data delved into the rates, risk factors, management strategies and outcomes of post-intravitreal anti-VEGF injection endophthalmitis.
“The AAO’s IRIS Registry is the world’s largest subspecialty clinical database at this time. Established in 2014, there are over 440 million unique patient visits. Nearly three-quarters of practicing ophthalmologists in the United States currently participate,” Alia K. Durrani, MD, said at the American Society of Retina Specialists annual meeting.
Of the 20.1 million injections reported in